Real, Luis M. http://orcid.org/0000-0003-4932-7429
Macías, Juan
Pérez, Ana B.
Merino, Dolores
Granados, Rafael
Morano, Luis
Delgado, Marcial
Ríos, María J.
Galera, Carlos
Deltoro, Miguel G.
Merchante, Nicolás
García, Federico http://orcid.org/0000-0001-7611-781X
Pineda, Juan A.
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (RD16/0025/0040, RD12/0017/0012, RD16/0025/0040, RD12/0017/0012, I3SNS)
Article History
Received: 16 May 2018
Accepted: 25 September 2018
First Online: 8 October 2018
Competing Interests
: J.M. has been an investigator in clinical trials supported by Bristol-Myers Squibb, Gilead and Merck Sharp & Dome. He has received lectures fees from Gilead, Bristol-Myers Squibb, and Merck Sharp & Dome, and consulting fees from Bristol Myers-Squibb, Gilead, and Merck Sharp & Dome. J.A.P. reports having received consulting fees from Bristol-Myers Squibb, Abbvie, Gilead, Merck Sharp & Dome, and Janssen Cilag. He has received research support from Bristol-Myers Squibb, Abbvie and Gilead and has received lecture fees from Abbvie, Bristol-Myers Squibb, Janssen Cilag, and Gilead. D.M. has received lectures fees from Abbvie, Gilead, ViiV Healthcare, Janssen Cilag, and Merck Sharp & Dome, and consulting fees from Janssen Cilag. The remaining authors declare no competing interests.